DE2604165A1 - Elektrodenanordnung - Google Patents
ElektrodenanordnungInfo
- Publication number
- DE2604165A1 DE2604165A1 DE19762604165 DE2604165A DE2604165A1 DE 2604165 A1 DE2604165 A1 DE 2604165A1 DE 19762604165 DE19762604165 DE 19762604165 DE 2604165 A DE2604165 A DE 2604165A DE 2604165 A1 DE2604165 A1 DE 2604165A1
- Authority
- DE
- Germany
- Prior art keywords
- electrode
- thrombogenic
- encapsulation
- stimulus
- electrode arrangement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000463 material Substances 0.000 claims description 26
- 230000001453 nonthrombogenic effect Effects 0.000 claims description 25
- 238000005538 encapsulation Methods 0.000 claims description 16
- 230000003176 fibrotic effect Effects 0.000 claims description 10
- 238000002513 implantation Methods 0.000 claims description 9
- 239000002296 pyrolytic carbon Substances 0.000 claims description 9
- 239000004020 conductor Substances 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000011810 insulating material Substances 0.000 claims description 4
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 description 11
- 208000007536 Thrombosis Diseases 0.000 description 8
- 229920002379 silicone rubber Polymers 0.000 description 8
- 239000004945 silicone rubber Substances 0.000 description 8
- 230000002885 thrombogenetic effect Effects 0.000 description 7
- 230000001684 chronic effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 5
- 108010073385 Fibrin Proteins 0.000 description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229950003499 fibrin Drugs 0.000 description 5
- 238000009413 insulation Methods 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229910001260 Pt alloy Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000020764 fibrinolysis Effects 0.000 description 3
- 239000012774 insulation material Substances 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 208000033988 Device pacing issue Diseases 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 102000002262 Thromboplastin Human genes 0.000 description 2
- 108010000499 Thromboplastin Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/0565—Electrode heads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54782275A | 1975-02-07 | 1975-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2604165A1 true DE2604165A1 (de) | 1976-08-19 |
Family
ID=24186276
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19767603022 Expired DE7603022U1 (de) | 1975-02-07 | 1976-02-04 | Biomedizinische reizelektrodenleitung zur dauernden implantation im lebenden koerper |
| DE19762604165 Ceased DE2604165A1 (de) | 1975-02-07 | 1976-02-04 | Elektrodenanordnung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19767603022 Expired DE7603022U1 (de) | 1975-02-07 | 1976-02-04 | Biomedizinische reizelektrodenleitung zur dauernden implantation im lebenden koerper |
Country Status (9)
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125116A (en) * | 1977-02-14 | 1978-11-14 | The Johns Hopkins University | Human tissue stimulation electrode structure |
| DE2842318A1 (de) * | 1978-09-28 | 1980-04-17 | Siemens Ag | Implantierbare kohlenstoffelektrode |
| EP0147710A3 (en) * | 1983-12-20 | 1986-02-05 | Siemens Aktiengesellschaft | Method of producing an implantable electrode |
| US4922910A (en) * | 1987-09-07 | 1990-05-08 | Aisin Seiki Kabushiki Kaisha | Cannula having an electrode |
| US5861023A (en) * | 1997-12-16 | 1999-01-19 | Pacesetter, Inc. | Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2533766C2 (de) * | 1975-07-29 | 1986-01-23 | Hans-Jürgen Dipl.-Ing. 5100 Aachen Bisping | Implantierbare transvenös einführbare Herzschrittmacherleitung |
| US4301815A (en) * | 1980-01-23 | 1981-11-24 | Telectronics Pty. Limited | Trailing tine electrode lead |
| US4328812A (en) * | 1980-03-21 | 1982-05-11 | Medtronic, Inc. | Ring electrode for pacing lead |
| US4497326A (en) * | 1981-04-06 | 1985-02-05 | Curry Paul V L | Heart pacing lead |
| DE3523226A1 (de) * | 1985-06-28 | 1987-01-08 | Osypka Peter | Defibrillations-elektrode |
| US4784161A (en) * | 1986-11-24 | 1988-11-15 | Telectronics, N.V. | Porous pacemaker electrode tip using a porous substrate |
-
1976
- 1976-01-01 AR AR26212176A patent/AR208018A1/es active
- 1976-01-21 AU AU10441/76A patent/AU502259B2/en not_active Expired
- 1976-02-04 DE DE19767603022 patent/DE7603022U1/de not_active Expired
- 1976-02-04 FR FR7603035A patent/FR2299873A1/fr active Granted
- 1976-02-04 DE DE19762604165 patent/DE2604165A1/de not_active Ceased
- 1976-02-04 NL NL7601113A patent/NL7601113A/xx unknown
- 1976-02-05 GB GB460576A patent/GB1537101A/en not_active Expired
- 1976-02-06 JP JP1357576U patent/JPS5514347Y2/ja not_active Expired
- 1976-02-06 CA CA245,213A patent/CA1063680A/en not_active Expired
- 1976-02-06 BR BR7600746A patent/BR7600746A/pt unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125116A (en) * | 1977-02-14 | 1978-11-14 | The Johns Hopkins University | Human tissue stimulation electrode structure |
| DE2842318A1 (de) * | 1978-09-28 | 1980-04-17 | Siemens Ag | Implantierbare kohlenstoffelektrode |
| EP0147710A3 (en) * | 1983-12-20 | 1986-02-05 | Siemens Aktiengesellschaft | Method of producing an implantable electrode |
| US4922910A (en) * | 1987-09-07 | 1990-05-08 | Aisin Seiki Kabushiki Kaisha | Cannula having an electrode |
| US5861023A (en) * | 1997-12-16 | 1999-01-19 | Pacesetter, Inc. | Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51105887U (enrdf_load_stackoverflow) | 1976-08-24 |
| CA1063680A (en) | 1979-10-02 |
| FR2299873B1 (enrdf_load_stackoverflow) | 1980-11-14 |
| AU502259B2 (en) | 1979-07-19 |
| JPS5514347Y2 (enrdf_load_stackoverflow) | 1980-04-01 |
| BR7600746A (pt) | 1976-08-31 |
| FR2299873A1 (fr) | 1976-09-03 |
| GB1537101A (en) | 1978-12-29 |
| DE7603022U1 (de) | 1976-11-04 |
| NL7601113A (nl) | 1976-08-10 |
| AR208018A1 (es) | 1976-11-22 |
| AU1044176A (en) | 1977-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0117972B1 (de) | Indifferente Elektrode für ein Herzschrittmachersystem | |
| US4033357A (en) | Non-fibrosing cardiac electrode | |
| DE69426814T2 (de) | Herzschrittmacher- und defibrillationselektrodenleitung, die die erfassung von signalen ermöglicht | |
| DE69514126T2 (de) | Durch Nähen permanent implantierte Elektrode zum Eluieren von Medikamenten | |
| DE3914662C2 (enrdf_load_stackoverflow) | ||
| DE69602011T2 (de) | Implantierbare stimulationselektroden | |
| DE69430934T2 (de) | Gesinterte Elektrode auf einem Substrat | |
| DE69824312T2 (de) | Verfahren und gerät zur beendigung von tachyarrhythmien | |
| DE69833361T2 (de) | Medizinische elektrische Zuleitung | |
| DE3628652C2 (enrdf_load_stackoverflow) | ||
| DE2652195C3 (de) | Herzschrittmacherelektrodenanordnung | |
| DE69518305T2 (de) | Herzschrittmacher mit universalem überzug | |
| DE69029564T2 (de) | Geflochtene Elektrodenleitungen und Katheter für ihre Benutzung | |
| DE69526496T2 (de) | In einem schritt implantierbarer medizinischer elektrischer leiter | |
| DE69409798T2 (de) | Hochfrequenzleiterbefestigung | |
| DE69011532T2 (de) | Nervenelektrode aus biologischem substrat. | |
| DE68919833T2 (de) | Intervenöse Leitung zur Reizung und Defibrillation. | |
| DE2643956C2 (de) | Elektrodensystem zur Rhythmuskorrektur eines funktionsgestörten Herzens | |
| DE4231600B4 (de) | Implantierbares Defibrillationssystem | |
| DE2613072B2 (de) | Implantierbare Elektrode | |
| DE19609471A1 (de) | Elektrodenanordnung | |
| DE3048805A1 (de) | Implantierbare leitung | |
| DE3015260A1 (de) | Endocard-elektrodenanordnung | |
| DE2809091A1 (de) | Herzschrittmacher | |
| DE2334049C2 (de) | Endocard-Elektrodenanordnung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |